TY  - GEN
AU  - Charles,Pierre
AU  - Bienvenu,Boris
AU  - Bonnotte,Bernard
AU  - Gobert,Pierre
AU  - Godmer,Pascal
AU  - Hachulla,Éric
AU  - Hamidou,Mohamed
AU  - Harlé,Jean-Robert
AU  - Karras,Alexandre
AU  - Lega,Jean-Christophe
AU  - Le Quellec,Alain
AU  - Mahr,Alfred D
AU  - Mouthon,Luc
AU  - Papo,Thomas
AU  - Puéchal,Xavier
AU  - Pugnet,Gregory
AU  - Samson,Maxime
AU  - Sibilia,Jean
AU  - Terrier,Benjamin
AU  - Vandergheynst,Frederick
AU  - Guillevin,Loïc
TI  - Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides
SN  - 2213-0276
PY  - 2013///1223
KW  - Adult
KW  - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
KW  - therapy
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - therapeutic use
KW  - Education, Medical, Continuing
KW  - France
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Immunotherapy
KW  - legislation & jurisprudence
KW  - Induction Chemotherapy
KW  - methods
KW  - Maintenance Chemotherapy
KW  - Prospective Studies
KW  - Rituximab
KW  - Societies, Medical
KW  - Surveys and Questionnaires
KW  - Vasculitis
KW  - etiology
N1  - Publication Type: Journal Article; Practice Guideline
UR  - https://doi.org/10.1016/j.lpm.2013.08.003
ER  -